ArticleBMC cancer2024

Clinical characteristics and survival of patients with de novo metastatic prostate cancer treated with androgen deprivation therapy and taxane-based chemotherapy in Uganda: a retrospective study.

Alex Bakenga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.